BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26237184)

  • 21. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
    Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
    Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
    [No Abstract]   [Full Text] [Related]  

  • 22. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.
    Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J
    Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
    Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
    Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
    Kapoor G; Sinha R; Naithani R; Chandgothia M
    Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
    Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
    BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia.
    Milosevic G; Kotur N; Krstovski N; Lazic J; Zukic B; Stankovic B; Janic D; Katsila T; Patrinos GP; Pavlovic S; Dokmanovic L
    J Med Biochem; 2018 Jul; 37(3):320-327. PubMed ID: 30598629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
    Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy.
    Smid A; Karas-Kuzelicki N; Milek M; Jazbec J; Mlinaric-Rascan I
    PLoS One; 2014; 9(10):e109551. PubMed ID: 25303517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
    Lopez-Lopez E; Ballesteros J; Piñan MA; Sanchez de Toledo J; Garcia de Andoin N; Garcia-Miguel P; Navajas A; Garcia-Orad A
    Pharmacogenet Genomics; 2013 Feb; 23(2):53-61. PubMed ID: 23222202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Karas-Kuzelicki N; Mlinaric-Rascan I
    Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of common and novel rare
    Zhu Y; Yin D; Su Y; Xia X; Moriyama T; Nishii R; Liao F; Zhang S; Guo X; Hou Q; Ai Y; Zhou X; Sun S; Zhang D; Zhang Y; Lin C; Deng Y; Lu X; Wang Y; Ma Z; Wang H; Liu B; Yang L; Zhang W; Yang JJ; Shu Y; Gao J; Xu H
    Haematologica; 2018 Jul; 103(7):e293-e295. PubMed ID: 29519865
    [No Abstract]   [Full Text] [Related]  

  • 33. Mercaptopurine-induced fever: hypersensitivity reaction in a patient with acute lymphoblastic leukemia.
    Chen LJ; Nightingale G; Baer MR
    Pharmacotherapy; 2010 Jan; 30(1):113. PubMed ID: 20030482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of childhood acute lymphoblastic leukemia.
    Lopez-Lopez E; Gutierrez-Camino A; Bilbao-Aldaiturriaga N; Pombar-Gomez M; Martin-Guerrero I; Garcia-Orad A
    Pharmacogenomics; 2014 Jul; 15(10):1383-98. PubMed ID: 25155938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
    Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
    J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.
    Organista-Nava J; Gómez-Gómez Y; Saavedra-Herrera MV; Rivera-Ramírez AB; Terán-Porcayo MA; Alarcón-Romero Ldel C; Illades-Aguiar B; Leyva-Vázquez MA
    Leuk Res; 2010 Jun; 34(6):728-32. PubMed ID: 20197200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of -24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia.
    Sharifi MJ; Bahoush G; Zaker F; Ansari S; Rafsanjani KA; Sharafi H
    Pediatr Hematol Oncol; 2014 Mar; 31(2):169-77. PubMed ID: 24552501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children.
    Al-Absi B; Noor SM; Saif-Ali R; Salem SD; Ahmed RH; Razif MF; Muniandy S
    Tumour Biol; 2017 Apr; 39(4):1010428317697573. PubMed ID: 28381164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism.
    Kim H; Kang HJ; Kim HJ; Jang MK; Kim NH; Oh Y; Han BD; Choi JY; Kim CW; Lee JW; Park KD; Shin HY; Ahn HS
    PLoS One; 2012; 7(9):e45558. PubMed ID: 23029095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.
    Aplenc R; Lange B
    Br J Haematol; 2004 May; 125(4):421-34. PubMed ID: 15142113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.